Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Reflex Testing for BRAF Mutational Status in Advanced Melanoma.

Archives of pathology & laboratory medicine - 1 Dec 2022

Tsang Matthew, Petkiewicz Stephanie

Abstract excerpt

CONTEXT.—: The use of targeted therapy in patients with advanced, BRAF-mutated melanomas has necessitated timely access to BRAF mutational status in order for clinicians to proceed with treatment decisions. OBJECTIVE.—: To assess the impact of pathologist-initiated reflex BRAF testing in patients with advanced melanoma on laboratory turnaround time and time to systemic treatment. DESIGN.—: At our tertiary care...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnostic Tests, Routine
Share to DNA Mutational Analysis
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Identifiers

PMID: 35344989
DOI: 10.5858/arpa.2021-0219-OA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Reflex Testing for BRAF Mutational Status in Advanced Melanoma.PMID 35344989Read ↗

Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre.Semantic proximity Read ↗

Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicineSemantic proximity Read ↗

Real-world frequency of BRAF testing and utilization of therapies in patients with advanced melanoma.Semantic proximity Read ↗

Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in MelanomaSemantic proximity Read ↗

Comparison of targeted next generation sequencing (NGS) versus isolated BRAF V600E analysis in patients with metastatic melanoma.Semantic proximity Read ↗

BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.Semantic proximity Read ↗

Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma.Semantic proximity Read ↗

Detection of BRAF mutation in metastatic melanoma utilizing cell-transferred cytological smears.Semantic proximity Read ↗

External quality assessment of BRAF molecular analysis in melanoma.Semantic proximity Read ↗

Preappointment testing for BRAF/KIT mutation in advanced melanoma: a model in molecular data delivery for individualized medicine.Semantic proximity Read ↗

Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma.Semantic proximity Read ↗

Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.